Molecular Theranostics: A New Era of Hope for End-Stage Cancer Patients
By Dr. Swagat Dash, HOD & Senior Consultant – Nuclear Medicine & Molecular Theranostics, Sarvodaya Hospital, Faridabad
At Sarvodaya Hospital, we are pioneering the future of cancer care with Molecular Theranostics – a revolutionary approach that combines diagnostics and therapy for highly personalised, targeted treatment. Especially beneficial for patients with advanced-stage cancers, this method offers new hope where conventional treatments may no longer be effective.
What is Molecular Theranostics?
Molecular Theranostics is a cutting-edge technique that integrates molecular imaging with targeted therapy. Using radiopharmaceuticals, this approach identifies disease-specific molecular markers and delivers treatment directly to the affected cells. It allows precise, non-invasive detection of diseases and ensures that therapy is tailored to the unique biology of each patient.
How It Works
The process begins with a low-dose radiopharmaceutical agent that targets specific cancer cell receptors. This helps in accurate imaging and diagnosis. The same agent, in a higher dose, is then used therapeutically to destroy cancer cells—while sparing healthy tissues. The result is an effective treatment with minimal side effects.
Next-Generation Nuclear Therapies
At Sarvodaya Hospital, we offer a range of advanced nuclear therapies that have shown promising outcomes, particularly for patients with resistant or metastatic cancers. These include:
-
Radioiodine Therapy for Thyroid Cancer
-
Lutetium PSMA & Alpha PSMA Therapy for Advanced Prostate Cancer
-
PRRT – DOTATATE Therapy for Neuroendocrine Tumours
-
Lutetium/Actinium FAPI Peptide Targeted Therapy for terminal-stage cancers (Lung, Breast, Pancreas, Gall Bladder, Ovary, Sarcoma, etc.)
-
TARE (Trans Arterial Radioembolization) for Liver Cancer
These therapies go beyond just cancer—they are increasingly being explored for non-cancerous conditions as well.
Benefits of Nuclear Medicine Therapy
Nuclear medicine offers a personalised, precise, and patient-friendly approach to treatment. Key advantages include:
-
Accurate localisation and targeted treatment of cancer cells
-
Minimal impact on healthy tissues, reducing side effects
-
Individualised therapy plans based on genomic and molecular analysis
This makes it an ideal option for patients who have undergone multiple lines of conventional treatment with limited success.
The Future of Nuclear Medicine
With rapid advancements in technology and research, nuclear medicine is poised to transform not just oncology but also fields like cardiology, neurology, and infectious diseases. Some of the emerging trends include:
-
Development of novel radiopharmaceuticals for improved targeting
-
Integration with artificial intelligence for better diagnostics and treatment planning
-
Enhanced global production of medical isotopes for broader accessibility
-
Improved safety and regulatory standards to support clinical efficacy
Why Choose Sarvodaya Hospital?
Sarvodaya Hospital, Faridabad, is at the forefront of Molecular Theranostics in India. With expert clinicians, state-of-the-art nuclear medicine facilities, and a commitment to personalised care, we aim to offer every patient a renewed chance at life—even in the most challenging stages of illness.
Source:- Click Here
